From Neoantigens to Nanocarriers: Modern Methods and Modalities in Using Peptides for Cancer Vaccination.

Area of Science:

• Oncology
• Immunology
• Vaccinology

Background:

• Cancer vaccines require sustained immune activation for tumor cell destruction.
• Few therapeutic cancer vaccines are FDA-approved due to targeting and immune response challenges.
• Peptides offer advantages like receptor interaction and low manufacturing cost for cancer therapy.

Purpose of the Study:

• To review recent advancements in peptide-based vaccine design for cancer.
• To explore optimal peptide vaccine formulations for sustained immune stimulation.
• To identify neoantigens for targeted tumor delivery of peptide antigens.

Main Methods:

• Review of current literature on peptide vaccine design and development.
• Analysis of strategies for neoantigen identification and isolation.
• Examination of methods for targeted delivery of peptide antigens.

Main Results:

• Peptides are promising for cancer vaccination due to their characteristics.
• Targeting specific neoantigens and optimizing delivery enhances vaccine efficacy.
• Further research is needed to refine peptide-based therapeutic strategies.

Conclusions:

• Peptide vaccines represent a growing area in cancer treatment.
• Optimized peptide vaccine design, including neoantigen targeting, can improve tumor regression.
• Peptide vaccines, especially in combination therapies, are revolutionizing cancer care possibilities.